[AHA] Contribution ofAPOEGenetic Variants to Dyslipidemia |
|
This post will be closed automatically in 2026-10-25 21:15
Reward10points
|
30
Drug-Coated Balloons or Drug-Eluting Stents for In-Stent Restenosis. Is That the Question?
30
Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial
10
Effect of Continuous Positive Airway Pressure on Intrathoracic and Left Ventricular Transmural Pressures in Patients With Congestive Heart Failure
10
Contribution ofAPOEGenetic Variants to Dyslipidemia
10
GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development
